Effect of Lactobacillus brevis ATCC 8287 as a feeding supplement on the performance and immune function of piglets.
- 2014-03
- Veterinary Immunology and Immunopathology 158(1-2)
- Tanja Lähteinen
- A. Lindholm
- T. Rinttilä
- S. Junnikkala
- R. Kant
- T. Pietilä
- K. Levonen
- I. von Ossowski
- G. Solano-Aguilar
- M. Jakava-Viljanen
- A. Palva
- PubMed: 24074625
- DOI: 10.1016/j.vetimm.2013.09.002
Abstract
Lactobacillus brevis ATCC 8287, a surface (S-layer) strain, possesses a variety of functional properties that make it both a potential probiotic and a good vaccine vector candidate. With this in mind, our aim was to study the survival of L. brevis in the porcine gut and investigate the effect of this strain on the growth and immune function of recently weaned piglets during a feeding trial. For this, 20 piglets were divided evenly into a treatment and a control group. Piglets in the treatment group were fed L. brevis cells (1×10(10)) daily for three weeks, whereas those in the control group were provided an equivalent amount of probiotic-free placebo. For assessing the impact of L. brevis supplementation during the feeding trial, health status and weight gain of the piglets were monitored, pre- and post-trial samples of serum and feces were obtained, and specimens of the small and large intestinal mucosa and digesta were collected at slaughter. The results we obtained indicated that L. brevis-supplemented feeding induced a non-significant increase in piglet body weight and caused no change in the morphology of the intestinal mucosa. L. brevis cells were found to localize mainly in the large intestine, but they could not be isolated from feces. To a lesser extent, L. brevis was detected in the small intestine, although there was no specific attachment to the Peyer's patches. Changes in total serum IgG and IgA concentrations were not caused by supplemented L. brevis and no measurable rise in L. brevis-specific IgG was observed. However, analysis of cytokine gene expression in intestinal mucosa revealed downregulation of TGF-β1 in the ileum and upregulation of IL-6 in the cecum in the L. brevis-supplemented group. Based on the results from this study, we conclude that whereas L. brevis appears to have some intestinal immunomodulatory effects, the ability of this strain to survive and colonize within the porcine gut appears to be limited.
Keywords: Immunomodulation; Lactobacilli; Lactobacillus brevis; Probiotics; Swine; Vaccine vector.
Research Insights
Supplement | Health Outcome | Effect Type | Effect Size |
---|---|---|---|
Lactobacillus brevis | Increased Body Weight | Neutral | Small |
Lactobacillus brevis | Increased IL-6 Levels in Cecum | Neutral | Small |
Lactobacillus brevis | Reduced TGF-beta Levels | Beneficial | Small |
Lactobacillus brevis | Unchanged Intestinal Morphology | Neutral | Small |
Lactobacillus brevis HA-112 | Altered Intestinal Mucosa Cytokine Gene Expression | Neutral | Small |
Lactobacillus brevis HA-112 | Improved Piglet Body Weight | Neutral | Small |
Lactobacillus brevis LB01 | Change in Piglet Body Weight | Neutral | Small |
Lactobacillus brevis LB01 | Improved Intestinal Immunomodulatory Function | Neutral | Small |
Lactobacillus brevis Lbr-35 | Altered IL-6 Gene Expression in Cecum | Neutral | Small |
Lactobacillus brevis Lbr-35 | Increased Piglet Body Weight | Neutral | Small |
Lactobacillus brevis Lbr-35 | Increased TGF-β1 Gene Expression in Ileum | Neutral | Small |
Lactobacillus brevis MAK11L82B | Increased Body Weight | Neutral | Small |
Lactobacillus brevis MAK11L82B | Increased IL-6 Gene Expression in Cecum | Beneficial | Small |
Lactobacillus brevis MAK11L82B | Increased TGF-β1 Gene Expression in Ileum | Neutral | Small |
Lactobacillus brevis SBC8803 | Altered Cytokine Gene Expression | Neutral | Small |
Lactobacillus brevis SBC8803 | Change in Body Weight | Neutral | Small |
Lactobacillus brevis SBC8803 | Increased Immunoglobulin G Levels | Neutral | Small |
Lactobacillus brevis SBC8803 | Increased Presence of Bifidobacterium lactis | Neutral | Small |
Lactobacillus brevis SD-5214 | Altered Intestinal Mucosa Morphology | Neutral | Small |
Lactobacillus brevis SD-5214 | Downregulated TGF-β1 Levels in the Ileum | Neutral | Small |
Lactobacillus brevis SD-5214 | Gut Localization of Lactobacillus brevis | Neutral | Small |
Lactobacillus brevis SD-5214 | Increased IL-6 Levels in Cecum | Neutral | Small |
Lactobacillus brevis UALbr-02 | Improved Gastrointestinal Health | Neutral | Small |
Lactobacillus brevis UALbr-02 | Increased IL-6 Gene Expression in Cecum | Beneficial | Small |
Lactobacillus brevis UALbr-02 | Increased L. brevis-specific IgG Concentrations | Neutral | Small |
Lactobacillus brevis UALbr-02 | Increased TGF-β1 Gene Expression in Ileum | Neutral | Small |
Lactobacillus brevis UALbr-02 | Reduced Body Weight | Neutral | Small |
Lactobacillus brevis VPro 18 | Downregulated TGF-β1 Levels in Ileum | Neutral | Small |
Lactobacillus brevis VPro 18 | Increased Body Weight | Neutral | Small |
Lactobacillus brevis VPro 18 | Increased IL-6 Levels in Cecum | Neutral | Small |
Lactobacillus brevis VPro 18 | No Change in Intestinal Mucosa Morphology | Neutral | Small |